A phase II trial of adjuvant cisplatin and doxorubicin in stage I epithelial ovarian cancer.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/FAC95B47.svg?ark=w1%2F20260515%2FFAC95B47)](https://nobleid.org/work/w1/20260515/FAC95B47)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors